Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-05-07 @ 7:44 AM
Study NCT ID:
NCT01037205
Status:
COMPLETED
Last Update Posted:
2014-04-08
First Post:
2009-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
Sponsor:
Ansun Biopharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAS181 - 2 - 03 (DMID 09-0090)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |